Clinical Trial Update: Extension Study of MT-1303 in Subjects With Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 extension study update for MT-1303 in Crohn's Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• MT-1303

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED